Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05237427
Other study ID # 100
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 1, 2020
Est. completion date January 18, 2023

Study information

Verified date March 2023
Source Kutahya Health Sciences University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to determine the reference value ranges for healthy adults of the incremental threshold load test, which evaluates respiratory muscle endurance.


Description:

Since respiratory muscles are used in daily life at the submaximal level, evaluation of their endurance is more meaningful functionally. In addition, evaluation of endurance with respiratory muscle strength is effective in determining respiratory muscle dysfunction. Failure to routinely evaluate respiratory muscle endurance, which is one of the main components of respiratory muscle function, may lead to failure to identify respiratory muscle dysfunction in early stage respiratory patients who have not yet developed muscle strength loss. However, normal value ranges have not been determined for the respiratory muscle endurance test. Determining the normal value ranges for this test will help determine muscle fatigue and investigate the physiological course in respiratory diseases.


Recruitment information / eligibility

Status Completed
Enrollment 112
Est. completion date January 18, 2023
Est. primary completion date September 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Being between the ages of 18-35 - Not having any disease - Not exercising regularly - Not smoking Exclusion Criteria: - Having a respiratory disease - Have heart disease - Have a neuromuscular disease - Have Scoliosis - Having had thoracic surgery - Having experienced the respiratory muscle endurance protocol before

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Kutahya Health Sciences University Kutahya

Sponsors (1)

Lead Sponsor Collaborator
Kutahya Health Sciences University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Other Anthropometric assessment Body weight was assessed with a digital scale in the orthostatic position, without shoes, with minimal clothing. Height was measured with the feet parallel and adjacent to each other, the arms extended by the body, and the head in a neutral position. Correlations between inspiratory muscle endurance of the incremental threshold loading protocol and anthropometric characteristics will be shown. 5 minute
Primary Incremental threshold loading test. A measure of endurance of inspiratory muscles. 15 minute
Primary Maximal inspiratory pressure A measure of the strength of inspiratory muscles 20 minute
Secondary Pulmonary function test - Forced expiratory volume in 1 second (FEV1) The forced expiratory volume in 1 second (FEV1) is the volume of air (in liters) exhaled in the first second during forced exhalation after maximal inspiration. It is lung function test that are measured during spirometry. This pulmonary function test measurements were made to confirm that the respiratory function parameters of the participants were within the normal range. . 5 minute
Secondary Pulmonary function test - Forced vital capacity (FVC) Forced vital capacity (FVC) is lung function test that are measured during spirometry. This pulmonary function test measurement is applied to confirm that the respiratory function parameters of the participants were within the normal range. 5 minute
Secondary Maximal voluntary ventilation (MVV) It is a test that measures inspiratory endurance. MVV is the largest amount of air that a person can inhale and then exhale during a 12- to 15-s interval with maximal voluntary effort. It is determined by spirometry measurement. 5 minute
Secondary International Physical Activity Questionnaire - Short Form This questionnaire assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in the metabolic equivalent of task (MET)-minute/week and time spent sitting. 5 minute
See also
  Status Clinical Trial Phase
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1